Clinical Trials Browser

Phase 2 × Carcinoma, Intraductal, Noninfiltrating × sargramostim × Clear all

NCT02636582 2023-12-05

Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer

Phase 2 Completed

43 enrolled 10 charts

Carcinoma, Intraductal, Noninfiltrating